PREVALENCE AND OUTCOMES OF UNCOMMON BCR-ABL FUSION TRANSCRIPTS IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA: DATA FROM A SINGLE CENTER

EHA Library, Ya-Zhen Qin, 214843

UPDATED RESULTS FROM THE ONGOING PHASE I STUDY OF PF-114 MESYLATE IN PATIENTS WITH CML WITH FAILURE OF PRIOR TKI THERAPY

EHA Library, Anna turkina, 214844

VARIATION IN LIMIT OF BLANK FOR BCR-ABL1 DETECTION BETWEEN LABORATORIES IMPACTS ON SCORING OF DEEP MOLECULAR RESPONSE

EHA Library, Helen White, 214845

DIGITAL PCR IN PH+ CHRONIC MYELOID LEUKEMIA PATIENTS FOR RECOGNITION OF “STABLE” DEEP MOLECULAR RESPONSE AND IDENTIFICATION OF BEST CANDIDATES TO TKI DISCONTINUATION

EHA Library, Michele Malagola, 214846

FIRST INTERIM ANALYSIS OF THE RUSSIAN MULTICENTER PROSPECTIVE STUDY RU-SKI: DISCONTINUATION OF TYROSINE KINASE INHIBITORS IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA AND DEEP MOLECULAR RESPONSE

EHA Library, Ekaterina Chelysheva, 214847

RESULTS OF TREATMENT OF PATIENTS WITH CHRONIC MYELOID LEUKEMIA AND PREGNANCY IN ACCORDANCE WITH THE LEUKEMIC BURDEN AND TERM OF PREGNANCY (THE LET SCHEME)

EHA Library, Ekaterina Chelysheva, 214848

ALLOGENEIC STEM CELL TRANSPLANTATION FOR CHRONIC MYELOID LEUKEMIA IN THE TKI ERA: POPULATION BASED DATA FROM THE SWEDISH CML REGISTRY.

EHA Library, Anna Lübking, 214849

LONG-TERM TREATMENT-FREE REMISSION (TFR) FOLLOWING SECOND-LINE (2L) NILOTINIB (NIL) IN PATIENTS (PTS) WITH CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE (CML-CP): ENESTOP 144-WK RESULTS

EHA Library, Tim Hughes, 214850

NILOTINIB VERSUS NILOTINIB COMBINED TO PEGYLATED-INTERFERON ALFA 2A IN FIRST-LINE CHRONIC PHASE CML PATIENTS. UPDATED INTERIM ANALYSIS OF A PHASE III TRIAL

EHA Library, Franck Emmanuel Nicolini, 214851

THE VALUE OF BCR-ABL1 QPCR LEVEL AND DOUBLING TIME (DT) TO PREDICT SUCCESSFUL TREATMENT-FREE REMISSION AFTER IMATINIB DISCONTINUATION: TREATMENT-FREE REMISSION ACCOMPLISHED BY DASATINIB (TRAD) TRIAL

EHA Library, Dennis Kim, 214852

ADDRESSING THE DIAGNOSTIC GAPS IN PYRUVATE KINASE (PK) DEFICIENCY. CONSENSUS RECOMMENDATIONS ON THE DIAGNOSIS OF PK DEFICIENCY

EHA Library, Paola Bianchi, 214853

GENETIC MARKERS AND NEW TARGET GENES IN THE DIAGNOSIS OF RARE ANAEMIAS

EHA Library, Juan-Luis Vives Corrons, 214854

ACTIVATE: A PHASE 3, RANDOMIZED, MULTICENTER, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF AG-348 IN ADULTS WITH PYRUVATE KINASE DEFICIENCY WHO ARE NOT REGULARLY TRANSFUSED

EHA Library, Marie-Hélène Jouvin, 214855

PYRUVATE KINASE DEFICIENCY IN JAPAN: A SUMMARY OF CLINICAL FEATURE, LABORATORY DATA AND ENZYMATIC DIAGNOSIS

EHA Library, Taiju Utsugisawa, 214856

ACTIVATE-T: A PHASE 3, OPEN-LABEL STUDY TO EVALUATE THE EFFICACY AND SAFETY OF AG-348 IN REGULARLY TRANSFUSED ADULTS WITH PYRUVATE KINASE DEFICIENCY

EHA Library, Marie-Hélène Jouvin, 214857

CLASSIFYING, SHARING AND REVIEWING GENETIC VARIANTS ASSOCIATED WITH RED CELL DISORDERS

EHA Library, Philip Davidson, 214858

HIGH SUCCESS RATE OF TARGETED NEXT GENERATION SEQUENCING FOR THE DIAGNOSIS OF PATIENTS WITH RARE CONGENITAL ANEMIAS

EHA Library, Orna Steinberg Shemer, 214859

DIAGNOSIS OF RARE CONGENITAL HEMOLYTIC ANEMIAS ENABLED BY NEXT GENERATION SEQUENCING PANEL

EHA Library, Paola Bianchi, 214860

NEXT GENERATION SEQUENCING FOR DIAGNOSIS OF INHERITED HEMOLYTIC ANEMIAS

EHA Library, Jorge Martínez Nieto, 214861

REPORT OF THE FIRST CASE OF HEREDITARY SPHEROCYTOSIS DUE TO A LARGE DELETION OF THE SPTA1 GENE

EHA Library, Patricia Aguilar-Martinez, 214862

CLINICAL CHARACTERISTICS OF PATIENTS WITH RED CELL PYRUVATE KINASE DEFICIENCY IN GERMANY

EHA Library, Paraskevi Klothaki, 214863

ANTITUMOR ACTIVITY BY TEGS: ALPHA/BETA T CELLS ENGINEERED TO EXPRESS A DEFINED GAMMA/DELTA TCR IN A 3D BONE MARROW NICHE MODEL OF MULTIPLE MYELOMA

EHA Library, Jurgen Kuball, 214864

LENALIDOMIDE AND PROGRAMMED DEATH-1 BLOCKADE SYNERGISTICALLY ENHANCES THE EFFECTS OF DENDRITIC CELL VACCINATION IN A MODEL OF MURINE MYELOMA

EHA Library, Je-Jung Lee, 214865

ANTI-CD19 CAR T-CELL THERAPY IN ADULTS WITH RELAPSED/REFRACTORY AGGRESSIVE B-CELL MALIGNANCIES AS A BRIDGE TO ALLOGENEIC TRANSPLANTATION – THE EXPEIENCE OF A SINGLE CENTER

EHA Library, Abraham Avigdor, 214866

EARLY MRD NEGATIVITY PREDICTS DEEPENING MYELOMA RESPONSE IN RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) PATIENTS TREATED WITH BB2121 ANTI-BCMA CAR T CELLS.

EHA Library, Nikhil Munshi, 214867

FIRST-LINE THERAPY WITH DONOR DERIVED HCMV-SPECIFIC T CELLS PROMOTES ANTIVIRAL IMMUNITY BY RESTORING THE QUANTITY AND FUNCTION OF RECIPIENT’S ENDOGENOUS HCMV-SPECIFIC T CELLS AFTER ALLO-HSCT

EHA Library, Xiangyu Zhao, 214868

LONG TERM OUTCOMES OF TABELECLEUCEL (ALLOGENEIC THIRD-PARTY EBV-TARGETED CYTOTOXIC T LYMPHOCYTES) FOR RITUXIMAB-REFRACTORY POST-TRANSPLANT EBV+ LYMPHOMAS: A SINGLE CENTER EXPERIENCE

EHA Library, Susan Prockop, 214869

THE EFFICACY AND SAFETY OF HUMANIZED CD19 CAR-T CELLS FOR RELAPSED OR REFRACTORY B-CELL NON-HODGKIN LYMPHOMA (NHL): A PRELIMINARY REPORT

EHA Library, Hong-Hui Huang, 214870

LIVE ATTENUATED VARICELLA ZOSTER VIRUS VACCINATION TO ADULT T-CELL LEUKEMIA/LYMPHOMA PATIENTS CAN INDUCE TUMOR SPECIFIC CELLULAR IMMUNITY.

EHA Library, Tatsuro Jo, 214871

PRODUCTION OF ARI-0001 CELLS (A3B1:CD8:4-1BB:CD3Z CAR19 CELLS) IN PATIENTS WITH CD19+ RELAPSED/REFRACTORY B-CELL MALIGNANCIES USING THE CLINIMACS PRODIGY SYSTEM

EHA Library, Julio Delgado, 214872

BLOOD-CIRCULATING BILE ACIDS SUPPORT EXPANDING HEMATOPOIETIC STEM AND PROGENITOR CELLS AND IMPROVE RECOVERY FROM MYELOSUPPRESSIVE CHEMOTHERAPY

EHA Library, Valgardur Sigurdsson, 214873

EARLY GROWTH RESPONSE (EGR)-1 IS A KEY REGULATOR OF HUMAN PRIMARY BONE MARROW STROMA CELLS WITH A DUAL ROLE IN PROLIFERATION AND HEMATOPOIETIC STROMA SUPPORT FUNCTION.

EHA Library, Stefan SCHEDING, 214874

A SINGLE-CELL RNA-SEQUENCING ATLAS OF THE MOUSE SPLEEN

EHA Library, Raghav Chawla, 214875

BONE MARROW ERYTHROPOIETIC DEFECT ACCOMPANYING EXTRAMEDULLARY HEMATOPOIESIS IS MIMICKED BY DOWNREGULATION OF NOTCH SIGNALING IN SPECIFIC MICROENVIRONMENT.

EHA Library, Tatsuhiro Sakamoto, 214876

HIERARCHICALLY RELATED LINEAGE-RESTRICTED FATES BY MULTIPOTENT HEMATOPOIETIC STEM CELLS

EHA Library, Petter Woll, 214877

CELLULAR AND MOLECULAR MAPPING OF HUMAN EARLY LYMPHOID PROGENITOR CELLS SUBMITTED TO LOW OXYGEN DOSES

EHA Library, SARA CHABI, 214879

HUMAN ADULT HSCS CAN BE DISCRIMINATED FROM LINEAGE-COMMITTED HPCS BY THE EXPRESSION OF ENDOMUCIN

EHA Library, Kristian Reckzeh, 214880

ROS-DEPENDENT SELF-RENEWAL DEFECTS OF HUMAN HEMATOPOIETIC STEM CELLS AFTER EXPOSURE TO LOW DOSE OF IONIZING RADIATIONS

EHA Library, Marie-Laure Arcangeli, 214881

THE HISTONE CHAPERONE NAP1L3 IS REQUIRED FOR HEMATOPOIETIC STEM CELL MAINTENANCE AND DIFFERENTIATION

EHA Library, GÖZDE TURKÖZ, 214882

PROSPECTIVELY ISOLATED BONE MARROW STROMAL CELLS FROM PATIENTS WITH HEMATOLOGICAL MALIGNANCIES DIFFER PHENOTYPICALLY AND RELATE TO DISEASE STAGE IN MGUS/MYELOMA

EHA Library, Stefan SCHEDING, 214883

PROGRAMMED DEATH LIGAND 1 EXPRESSION IN THE MICROENVIRONMENT OF CLASSICAL HODGKIN LYMPHOMA IS INDUCED BY LYMPHOMA CELLS VIA AN IL27-DEPENDENT MECHANISM

EHA Library, Joseph Taylor, 214884

TARGETING ROR1 RECEPTOR IN CLASSICAL HODGKIN LYMPHOMA: EFFECTS ON APOPTOSIS AND PROLIFERATION AND ITS EMERGING THERAPEUTIC IMPLICATIONS

EHA Library, Louloudenia Velentza, 214885

TREATMENT RELATED INCIDENCE OF DISEASES OF THE CIRCULATORY SYSTEM IN PATIENTS DIAGNOSED WITH HODGKIN LYMPHOMA

EHA Library, Caroline Weibull, 214886

ACTIVATED CASPASE-3 EXPRESSION BY HODGKIN AND REED-STERNBERG CELLS (HRS) IS A POWERFUL PROGNOSTIC FACTOR IN CLASSICAL HODGKIN LYMPHOMA (CHL) TREATED WITH ABVD OR EQUIVALENT REGIMENS

EHA Library, Theodoros Vassilakopoulos, 214887

RISK OF SECOND MALIGNANCIES IN HODGKIN LYMPHOMA PATIENTS IN THE NEW MILLENNIUM: REAL WORLD EVIDENCE FROM THE SEER DATABASE

EHA Library, Velizar Shivarov, 214888

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION AFTER NIVOLUMAB TREATMENT IN RELAPSED/REFRACTORY HODGKIN LYMPHOMA

EHA Library, Jean-Baptiste Mear, 214889

INTERIM- PET RESULTS FOR PROGNOSIS IN ADULTS WITH HODGKIN LYMPHOMA: A PROGNOSTIC FACTOR EXEMPLAR REVIEW (PRELIMINARY RESULTS)

EHA Library, Angela Aldin, 214890

DOWNREGULATION OF STATS DETERMINE POOR PROGNOSIS IN HODGKIN’S LYMPHOMA.

EHA Library, Ahmad Zargari, 214891

A PHASE 1 STUDY INVESTIGATING THE COMBINATION OF AFM13 AND PEMBROLIZUMAB IN PATIENTS WITH RELAPSED/REFRACTORY HODGKIN LYMPHOMA AFTER BRENTUXIMAB VEDOTIN FAILURE: UPDATED SAFETY AND EFFICACY DATA.

EHA Library, Andras Strassz, 214892

PAEDIATRIC HODGKIN LYMPHOMA IN VERY YOUNG PATIENTS: THE ITALIAN EXPERIENCE

EHA Library, Piero Farruggia, 214893

NIVOLUMAB IN COMBINATION WITH BRENTUXIMAB VEDOTIN IN PATIENTS WITH RELAPSED OR REFRACTORY HODGKIN’S LYMPHOMA AFTER FAILURE OF NIVOLUMAB MONOTHERAPY

EHA Library, Luibov Tsvetkova, 214894

THE COMBINATION OF ALISERTIB AND ROMIDEPSIN IS A SAFE AND EFFECTIVE REGIMEN FOR RELAPSED/REFRACTORY AGGRESSIVE HODGKIN AND T-CELL LYMPHOMAS: A PHASE 1 STUDY

EHA Library, Paolo Strati, 214895

ΔSUVMAX AND ΔSUVPEAK IMPROVE THE NEGATIVE PREDICTIVE VALUE OF INTERIM PET SCAN IN HODGKIN LYMPHOMA

EHA Library, Teresa Ribeiro, 214896

OUTCOME OF ELDERLY PATIENTS WITH CLASSICAL HODGKIN LYMPHOMA IN CENTRAL SCOTLAND, UK

EHA Library, Mark Rafferty, 214897

LONG-TERM FOLLOW-UP OF VEMURAFENIB IN BRAF MUTANT HAIRY CELL LEUKEMIA SHOWS DURABLE REMISSIONS AND HIGH RESPONSE RATES WITH REPEATED TREATMENT WITH VEMURAFENIB AT RELAPSE

EHA Library, Jae H. Park, 214898

METABOLIC (PET) AND MRD RESPONSE CONFER REDUCED RISK OF PROGRESSION OR DEATH IN PATIENTS TREATED WITHIN THE PHASE III GALLIUM STUDY

EHA Library, Christiane Pott, 214899

THE DUAL SYK/JAK INHIBITOR CERDULATINIB DEMONSTRATES RAPID TUMOR RESPONSES IN A PHASE 2A STUDY IN PATIENTS WITH RELAPSED/REFRACTORY B- AND T-CELL NON-HODGKIN LYMPHOMA (NHL)

EHA Library, Paul A. Hamlin, 214900

ACALABRUTINIB ALONE OR IN COMBINATION WITH RITUXIMAB IN FOLLICULAR LYMPHOMA

EHA Library, Nathan H. Fowler, 214901

RESPONSE RATE TO LENALIDOMIDE PLUS RITUXIMAB (R2) IS INDEPENDENT OF RITUXIMAB-REFRACTORY STATUS: INITIAL INTERIM ANALYSIS OF MAGNIFY PHASE IIIB STUDY OF R2 FOLLOWED BY MAINTENANCE IN R/R INDOLENT NHL

EHA Library, Mathias J. Rummel, 214902

RESULTS OF A DOSE ESCALATION STUDY OF ME-401, A SELECTIVE PI3KΔ INHIBITOR, IN RELAPSED/REFRACTORY (R/R) FOLLICULAR LYMPHOMA (FL) AND CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)/SMALL LYMPHOCYTIC LYMPHOMA (SLL)

EHA Library, John M Pagel, 214903

SHORT DIAGNOSIS TO TREATMENT INTERVAL IS ASSOCIATED WITH POOR OUTCOMES IN PATIENTS WITH FOLLICULAR LYMPHOMA TREATED WITH IMMUNOCHEMOTHERAPY

EHA Library, Michael Clausen, 214904

NEW ASSESSMENT INDEX OF CLINICAL TRANSFORMATION FROM FOLLICULAR LYMPHOMA (FL) TO DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) IN THE RITUXIMAB ERA

EHA Library, Takafumi Shichijo, 214905

LONG TERM INTEGRATED SAFETY ANALYSIS OF UMBRALISIB (TGR-1202), A PI3K-DELTA/CK1-EPSILON INHIBITOR WITH A DIFFERENTIATED SAFETY PROFILE, IN PATIENTS WITH RELAPSED/REFRACTORY LYMPHOID MALIGNANCIES

EHA Library, Matthew S. Davids, MD, MMSC, 214906

POOLED ANALYSIS OF SAFETY DATA FROM ZANUBRUTINIB (BGB-3111) MONOTHERAPY STUDIES IN HEMATOLOGIC MALIGNANCIES

EHA Library, Constantine S Tam, 214907

R-ESHAP IS NOT EFFECTIVE AS SALVAGE THERAPY IN REFRACTORY FOLLICULAR LYMPHOMA: RESULTS OF A RETROSPECTIVE MULTICENTRE STUDY ON BEHALF OF GELCAB GROUP

EHA Library, Ana Muntañola, 214908

CHALLENGES IN DELIVERY OF MAINTENANCE ANTI-CD20 THERAPY IN ADVANCED FOLLICULAR LYMPHOMA: 5-YEAR EXPERIENCE AT THE ROYAL MARSDEN HOSPITAL

EHA Library, Hamzeh Kayhanian, 214909

OUTCOMES FOR DIABETIC PATIENTS FROM THE CHRONOS-1 STUDY WITH RELAPSED OR REFRACTORY INDOLENT B-CELL LYMPHOMA TREATED WITH COPANLISIB

EHA Library, Martin Dreyling, 214910

COMPARATIVE EFFICACY AND SAFETY OF DIFFERENT ANTIVIRAL AGENTS FOR CYTOMEGALOVIRUS PROPHYLAXIS AFTER HEMATOPOIETIC-CELL TRANSPLANTATION: A SYSTEMATIC REVIEW AND META-ANALYSES

EHA Library, Nico Gagelmann, 214911

CANDIDA-REACTIVE T CELLS FOR THE DIAGNOSIS OF INVASIVE CANDIDA INFECTION

EHA Library, Felix Koehler, 214912

TENOFOVIR VERSUS LAMIVUDINE FOR PREVENTION OF HEPATITIS B VIRUS REACTIVATION AMONG PATIENTS WITH AGGRESSIVE LYMPHOMAS UNDERGOING FRONT-LINE ANTHRACYCLINE-CONTAINING CHEMOTHERAPY

EHA Library, Irene Zacheo, 214913

SWITCHING FROM POSACONAZOLE ORAL SUSPENSION TO TABLETS INCREASES SERUM LEVELS, PRESERVES SAFETY AND IMPROVES TREATMENT SATISFACTION: A PROSPECTIVE CLINICAL TRIAL IN PATIENTS WITH ACUTE LEUKEMIA.

EHA Library, Rafael F Duarte, 214914

MURCORMYCOSIS AND ASPERGILLOSIS IN ONCOHEMATOLOGICAL PATIENTS: WHAT’S THE DIFFERENCE?

EHA Library, Nikolay Klimko, 214915

INVASIVE FUNGAL DISEASES CAUSED BY RARE PATHOGENS IN CHILDREN WITH HEMATOLOGICAL DISEASES AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION AND CHEMOTHERAPY

EHA Library, Marina Popova, 214916

INVASIVE ASPERGILLOSIS IN HAEMATOLOGICAL PATIENTS: A REVIEW OF 625 CASES

EHA Library, Raoul Herbrecht, 214917

DIAGNOSIS OF INVASIVE ASPERGILLOSIS IN HIGH RISK HEMATOLOGICAL MALIGNANCY PATIENTS: PERFORMANCE OF BIOMARKERS AND CYTOKINES IN SAME DAY BLOOD AND BRONCHOALVEOLAR LAVAGE FLUID SAMPLES.

EHA Library, Martin Hoenigl, 214918

NEUTROPHIL EXTRACELLULAR TRAPS IMPAIR FUNGAL CLEARANCE IN A MOUSE MODEL OF INVASIVE PULMONARY ASPERGILLOSIS

EHA Library, Astrid Alflen, 214919

HEMOPHAGOCYTIC LIMPHOHISTIOCYTOSIS ASSOCIATED WITH LEISHMANIASIS: A HIDDEN PASSENGER IN ENDEMIC AREAS?

EHA Library, Jon Badiola, 214920

ANALYSIS OF THE BURDEN OF CYTOMEGALOVIRUS REACTIVATION IN PATIENTS UNDERGOING HEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, Christopher Tham, 214921

ANTIGFUNGAL DRUGS MODULATE HUMAN NEUTROPHIL ACTIVITIES IN VITRO AND IN VIVO IN PATIENTS AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, Daniel Teschner, 214922

(1-3)-Β-D-GLUCAN ASSAY AND AIRWAY-INVASIVE RADIOLOGICAL FINDINGS AS EARLY SIGNS OF PULMONARY ASPERGILLOSIS IN HIGH-RISK HEMATOLOGIC PATIENTS IN THE POSACONAZOLE ERA: PRELIMINARY OBSERVATIONS

EHA Library, Claudia Giordano, 214923

COMPARATIVE ANALYSIS OF DETECTION OF EBV SMALL NON-CODING RNA (EBER) AND MARKERS OF ACUTE EBV INFECTION AT THE ONSET OF ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA

EHA Library, Natalia Chernova, 214924

THE ROLE OF SERUM GALACTOMANNAN ASSAY IN THE MANAGEMENT OF INVASIVE MOLD INFECTIONS IN AUTOLOGOUS HEMATOPOIETIC CELL TRANSPLANTATION.

EHA Library, María Esther Martínez-Muñoz, 214925

CYTOMEGALOVIRUS (CMV) IMPACT ON CLINICAL OUTCOMES AND RESOURCE USE AFTER ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION: THE INFLUENCE OF RECURRENT EPISODES OF CMV INFECTION

EHA Library, Carlos de Miguel Jiménez, 214926

EPIDEMIOLOGY AND TREATMENT APPROACHES OF INVASIVE FUNGAL INFECTIONS MANAGEMENT IN HEMATOLOGICAL MALIGNANCIES: RESULTS FROM A SINGLE-CENTRE STUDY

EHA Library, Nicola Stefano Fracchiolla, 214927

HERPES VIRUSES AT THE ONSET OF ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA. IS THERE AN ASSOCIATION?

EHA Library, Natalia Chernova, 214928

POST-TRANSPLANT EBSTEIN-BARR VIRAL LOAD MONITORING EXPERIENCE IN A HEMATOPOIETIC STEM CELL TRANSPLANTATION CENTER

EHA Library, Seda Balaban, 214929

ISAVUCONAZOLE SHORTENS THE QTC INTERVAL

EHA Library, Sibylle Mellinghoff, 214930

ALPHA LIPOIC ACID REDUCES THE TOXIC EFFECTS INDUCED BY IRON OVERLOAD TREATMENT: IN VITRO AND IN VIVO MODELS

EHA Library, Giuseppina CAMIOLO, 214931

A PHASE 1, PLACEBO-CONTROLLED STUDY TO DETERMINE THE SAFETY, TOLERABILITY, AND PHARMACOKINETICS OF ESCALATING SUBCUTANEOUS DOSES OF LJPC-401 (SYNTHETIC HUMAN HEPCIDIN) IN HEALTHY ADULTS

EHA Library, Antonis Kattamis, 214932

REPEATABILITY OF LIVER IRON CONCENTRATION MEASUREMENTS WITH MRI AND AN ARTIFICIAL NEURAL NETWORK DATA ANALYSIS SYSTEM

EHA Library, Tim St Pierre, 214933

IRON OVERLOAD FOLLOWING ALLOGENEIC HEMATOPOIETIC TRANSPLANTS: LONG-TERM OUTCOMES

EHA Library, Gloria Obi, 214934

IRON OVERLOAD INCREASES OXIDATIVE STRESS AND DECREASES CLONOGENIC CAPACITY OF CELLS IN MDS PATIENTS: CAN BE RESTORED AFTER DEFERASIROX TREATMENT?

EHA Library, María Díez Campelo, 214935

RISK OF OVERTREATMENT OF HAEMOCHROMATOSIS DUE TO CO-INHERITED HYPERFERRITINAEMIA-CATARACT SYNDROME

EHA Library, Hannah Cutts, 214936

AN OPEN-LABEL, MULTICENTER, SINGLE-ARM, PHASE II STUDY ASSESSING PATIENT PREFERENCE FOR THE DEFERASIROX FILM-COATED TABLET COMPARED TO THE REFERENCE DISPERSIBLE TABLET FORMULATION: THE JUPITER STUDY

EHA Library, Vip Viprakasit, 214937

A RARE CAUSE OF HEREDITARY HEMOCHROMATOSIS : COMPOUND HETEROZYGOSITY ASSOCIATING THE C282Y VARIATION WITH A PRIVATE HFE MUTATION - TWO CASES COMBINING NEW NONSENSE MUTATIONS.

EHA Library, severine cunat, 214938

THE RETICULOCYTE PARAMETERS: A NEW TOOL FOR ASSESSING AND MONITORING IRON HOMEOSTASIS

EHA Library, Maria Jose Teles, 214939

SYNERGISTIC EFFECTS OF PRIMA-1MET (APR-246) AND AZACITIDINE (AZA) IN TP53-MUTATED MYELODYSPLASTIC SYNDROMES

EHA Library, Stephane Giraudier, 214940

GENE PANEL ANALYSIS BY NEXT GENERATION SEQUENCING FOR THE DETECTION OF CLONAL HAEMATOPOIESIS IN IDIOPATHIC CYTOPENIA OF UNDETERMINED SIGNIFICANCE (ICUS) AND MYELODYSPLASTIC SYNDROME (MDS)

EHA Library, Yannick Wouters, 214941

IMPACT OF SOMATIC MUTATIONAL TESTING BY NEXT-GENERATION SEQUENCING (NGS) FOR SUSPECTED MYELODYSPLASIA OR MYELODYSPLASTIC/MYELOPROLIFERATIVE SYNDROMES IN “REAL-LIFE”.

EHA Library, Yannick Le Bris, 214942

PROGENITOR HYPERSENSITIVITY TO FLT3L GENERATES CLONAL PLASMACYTOID DENDRITIC CELLS IN CHRONIC MYELOMONOCYTIC LEUKEMIA

EHA Library, Nolwenn Lucas, 214943